| Literature DB >> 32670475 |
Akanksha N Thakkar1, Isaac Tea1, Mouaz H Al-Mallah1.
Abstract
Since early 2020, the world has been facing a pandemic caused by the novel coronavirus SARS-CoV-2. Although this positive single-stranded RNA virus primarily causes pulmonary infection and failure, it has been associated with multiple cardiovascular diseases including troponin elevation, myocarditis, and cardiac arrhythmias. Cardiac patients are susceptible to developing more severe infection from SARS-COV-2, making management complicated. In this review we discuss the cardiac manifestations of COVID-19 infections as well as considerations for the management of primary cardiac pathologies during this pandemic.Entities:
Keywords: ACE inhibitors; COVID-19; angiotensin receptor blockers; arrhythmias; cardiovascular imaging; coagulopathy; organ transplant; troponin
Mesh:
Substances:
Year: 2020 PMID: 32670475 PMCID: PMC7350814 DOI: 10.14797/mdcj-16-2-146
Source DB: PubMed Journal: Methodist Debakey Cardiovasc J ISSN: 1947-6108